Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - NET INCOME
Net Income URGN - UroGen Pharma Ltd.
-127 M
LAST VALUE
-7.50%
2 YEAR CAGR
-3.83%
5 YEAR CAGR
-39.72%
10 YEAR CAGR